Paper Details
- Home
- Paper Details
A dose-finding and discontinuation study of clomipramine in panic disorder.
Author: AndradeL, BernikM, CordasT, GentilV, GorensteinC, Lotufo-NetoF, MeloM, RamosR T
Original Abstract of the Article :
Eighty-one panic disorder patients with or without agoraphobia were treated with flexible doses of clomipramine under single-blind conditions. Fifty-seven (70.3%) reached operational criteria for full remission in 16.2 +/- 6.5 weeks, with a mean dose of 89.1 +/- 8.2 mg/day. Fifty-four (81%) of them ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1177/026988110101500103
データ提供:米国国立医学図書館(NLM)
Examining Clomipramine in Panic Disorder
This study delves into the efficacy of clomipramine in treating panic disorder, an area of great interest in the field of mental health. It employs a single-blind dose-finding approach to determine the optimal dosage and investigates the long-term effects of discontinuation. The researchers found that a significant majority of patients experienced full remission, with a mean dose of 89.1 mg/day. However, upon discontinuation, a substantial portion of patients experienced relapse, highlighting the need for ongoing maintenance therapy. The study also pinpoints predictors of early relapse, including higher baseline depression scores and greater reliance on high clomipramine doses to achieve remission.The Importance of Long-Term Treatment
The study's findings underscore the importance of long-term or intermittent maintenance therapy for many patients with panic disorder. The researchers found that 63% of patients were followed-up for up to 3 years, with 37.2% experiencing an early relapse, 43.1% experiencing a later recurrence, and only 19.6% remaining asymptomatic. This suggests that a substantial number of patients require ongoing treatment to manage their panic disorder effectively.Implications for Patient Care
The study's findings have crucial implications for the treatment of panic disorder. They suggest that while clomipramine can be effective in achieving remission, long-term management strategies are essential for many patients. Recognizing factors that predict early relapse, such as depression severity and clomipramine dose, can help clinicians tailor treatment plans and optimize patient outcomes.Dr. Camel's Conclusion
This study presents a comprehensive look at the complexities of treating panic disorder. The researchers provide valuable insights into the effectiveness of clomipramine, the importance of maintenance therapy, and the factors that influence relapse. As Dr. Camel, I am fascinated by the persistence of panic disorder in some patients, even after achieving remission. It's like a stubborn camel refusing to leave the oasis, even after finding a plentiful source of water! This research serves as a valuable guide for clinicians and patients alike, emphasizing the need for ongoing vigilance and tailored treatment approaches to effectively manage this challenging condition.Date :
- Date Completed 2001-07-19
- Date Revised 2017-02-14
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.